HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Marian M Haber Selected Research

lansoprazole (Prevacid)

5/2010Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole.
3/2010Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
8/2009Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.
5/2009Lansoprazole for long-term maintenance therapy of erosive esophagitis: double-blind comparison with ranitidine.
9/2002Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
1/2002Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Marian M Haber Research Topics

Disease

5Esophagitis
05/2010 - 06/2002
3Ulcer
09/2002 - 01/2002
2Gastritis
03/2010 - 07/2003
2Infection
03/2010 - 09/2002
2Inflammation
01/2010 - 11/2005
2Carcinoma (Carcinomatosis)
01/2006 - 01/2002
2Stomach Ulcer (Gastric Ulcer)
09/2002 - 01/2002
1Heartburn (Pyrosis)
05/2010
1Dyspepsia (Indigestion)
03/2010
1Liver Diseases (Liver Disease)
01/2010
1Short Bowel Syndrome
01/2010
1Diarrhea
10/2009
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2009
1Peptic Esophagitis (Reflux Esophagitis)
08/2009
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2007
1Adenocarcinoma
11/2007
1Neoplasms (Cancer)
01/2006
1Granuloma
11/2005
1Lymphoma (Lymphomas)
11/2005
1Barrett Esophagus (Barrett's Esophagus)
10/2005
1Mucocele
10/2003
1Colorectal Neoplasms (Colorectal Cancer)
10/2003
1Atrophic Gastritis
07/2003
1Ischemia
09/2002
1Reperfusion Injury
09/2002
1Critical Illness (Critically Ill)
09/2002

Drug/Important Bio-Agent (IBA)

6lansoprazole (Prevacid)FDA LinkGeneric
05/2010 - 01/2002
3Ranitidine (Zantac)FDA LinkGeneric
05/2010 - 09/2002
2Eosine Yellowish-(YS) (Eosin)IBA
01/2006 - 06/2002
2Hematoxylin (Haematoxylon)IBA
01/2006 - 06/2002
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2002 - 01/2002
1AntralIBA
03/2010
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2009
1HLA-B27 Antigen (HLA B27 Antigen)IBA
10/2009
1Fluconazole (Zonal)FDA LinkGeneric
11/2007
1ChromatinIBA
01/2006
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2005
1Orbital lymphomaIBA
11/2005
1AntibodiesIBA
10/2005
1Carcinoembryonic AntigenIBA
10/2003
1N 30IBA
07/2003
1Alanine (L-Alanine)FDA Link
09/2002
1Adenosine Triphosphate (ATP)IBA
09/2002
1SodiumIBA
09/2002
1Glucose (Dextrose)FDA LinkGeneric
09/2002
1Glutamine (L-Glutamine)FDA Link
09/2002
1Misoprostol (Cytotec)FDA LinkGeneric
01/2002
1Proton Pump InhibitorsIBA
01/2002
1AS 8IBA
01/2002

Therapy/Procedure

1Total Parenteral Nutrition
01/2010
1Prostatectomy (Retropubic Prostatectomy)
11/2007